Question 1

What is the catalog number for Cluster of Differentiation 109 (CD109) Porcine ELISA Kit?

Accepted Answer

The catalog number for Cluster of Differentiation 109 (CD109) Porcine ELISA Kit is C2226.

Question 2

What sizes are available for Cluster of Differentiation 109 (CD109) Porcine ELISA Kit?

Accepted Answer

Cluster of Differentiation 109 (CD109) Porcine ELISA Kit is available in the following size(s): 96 Tests.

Question 3

Is Cluster of Differentiation 109 (CD109) Porcine ELISA Kit in stock?

Accepted Answer

Cluster of Differentiation 109 (CD109) Porcine ELISA Kit is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Question 5

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 6

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Cluster of Differentiation 109 (CD109) Porcine ELISA Kit

Product Specifications

Frequently Asked Questions

Explore Other Products

Anti-OGDHL Antibody Picoband®, FITC Conjugate

DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/1485), CF405S conjugate, 0.1mg/mL

Anti-CCDC115 Antibody Picoband®, PE Conjugate

Cytokeratin 10 (Suprabasal Epithelial Marker) (rKRT10/1275), CF405S conjugate, 0.1mg/mL

Tyrosinase (Melanoma Marker) (TYR/2024R), 0.2mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 0.2mg/mL